{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:21:43Z","timestamp":1761513703731},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s40266-015-0303-8","type":"journal-article","created":{"date-parts":[[2015,10,6]],"date-time":"2015-10-06T13:46:22Z","timestamp":1444139182000},"page":"857-869","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Immunogenicity and Safety of Intradermal Influenza Vaccine in the Elderly: A Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.1007","volume":"32","author":[{"given":"Claudia","family":"Pileggi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Mascaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aida","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmelo G. A.","family":"Nobile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Pavia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,6]]},"reference":[{"key":"303_CR1","unstructured":"WHO. Global pandemic influenza action plan to increase vaccine supply: progress report 2006\u20132008. Geneva, 2009. http:\/\/whqlibdoc.who.int\/hq\/2009\/WHO_IVB_09.05_eng.pdf . Accessed 20 June 2013."},{"key":"303_CR2","first-page":"1151","volume":"12","author":"C Reed","year":"2014","unstructured":"Reed C, Kim IK, Singleton JA, et al. Estimated influenza illnesses and hospitalizations averted by vaccination\u2014United Stated, 2013\u201314 influenza season. MMWR Morb Mortal Wkly Rep. 2014;12:1151\u20134.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"303_CR3","unstructured":"ECDC. Seasonal influenza vaccination in Europe\u2014Overview of vaccination recommendations and coverage rates in the EU Member States for the 2012\u201313 influenza season. Stockholm: ECDC. 2015. http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/Seasonal-influenza-vaccination-Europe-2012-13.pdf . Accessed 30 Jan 2015."},{"key":"303_CR4","unstructured":"Raphael D. Chapter 180. Influenza. In: Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J, editors. Harrison\u2019s principles of internal medicine. 17th ed. New York: McGraw-Hill Co Inc; 2008. p. 1127\u201332."},{"key":"303_CR5","first-page":"1","volume":"59","author":"AE Fiore","year":"2010","unstructured":"Fiore AE, Uyeki TM, Broder K, et al. Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices (ACIP), 2010. MMWR Recomm Rep. 2010;59:1\u201362.","journal-title":"MMWR Recomm Rep."},{"key":"303_CR6","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1016\/j.vaccine.2004.01.068","volume":"22","author":"P Villari","year":"2004","unstructured":"Villari P, Manzoli L, Boccia A. Methodological quality of studies and patient age as major sources of variation in efficacy estimates of influenza vaccination in healthy adults: a meta-analysis. Vaccine. 2004;22:3475\u201386.","journal-title":"Vaccine."},{"key":"303_CR7","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1016\/j.vaccine.2009.06.032","volume":"27","author":"AS Monto","year":"2009","unstructured":"Monto AS, Ansaldi F, Aspinall R, et al. Influenza control in the 21st century: optimizing protection of older adults. Vaccine. 2009;27:5043\u201353.","journal-title":"Vaccine."},{"key":"303_CR8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/11586770-000000000-00000","volume":"28","author":"V Parodi","year":"2011","unstructured":"Parodi V, de Florentiis D, Martini M, et al. Inactivated influenza vaccines: recent progress and implications for the elderly. Drugs Aging. 2011;28:93\u2013106.","journal-title":"Drugs Aging"},{"key":"303_CR9","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, et al. The PRISMA Group (2009): preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.","journal-title":"BMJ"},{"key":"303_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad AR, Moore RA, Carrol D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clin Trials. 1996;17:1\u201312.","journal-title":"Controlled Clin Trials."},{"key":"303_CR11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0197-2456(81)90056-8","volume":"2","author":"TC Chalmers","year":"1981","unstructured":"Chalmers TC, Smith H Jr, Blackburn B, et al. A method for assessing the quality of a randomized control trial. Controlled Clin Trials. 1981;2:31\u201349.","journal-title":"Controlled Clin Trials."},{"key":"303_CR12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials. 1986;7:177\u201388.","journal-title":"Controlled Clin Trials."},{"key":"303_CR13","first-page":"719","volume":"22","author":"N Mantel","year":"1959","unstructured":"Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719\u201348.","journal-title":"J Natl Cancer Inst"},{"key":"303_CR14","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SC. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539\u201358.","journal-title":"Stat Med"},{"key":"303_CR15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629\u201334.","journal-title":"BMJ"},{"key":"303_CR16","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088\u201399.","journal-title":"Biometrics."},{"key":"303_CR17","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1056\/NEJMoa043555","volume":"351","author":"RB Belshe","year":"2004","unstructured":"Belshe RB, Newman FK, Cannon J, et al. Serum antibody responses after intradermal vaccination against influenza. N Engl J Med. 2004;351:2286\u201394.","journal-title":"N Engl J Med"},{"key":"303_CR18","first-page":"650","volume":"198","author":"D Holland","year":"2008","unstructured":"Holland D, Booy R, De Looze F, et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. JID New Zealand. 2008;198:650\u20138.","journal-title":"JID New Zealand."},{"key":"303_CR19","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1016\/j.vaccine.2009.10.033","volume":"27","author":"R Arnou","year":"2009","unstructured":"Arnou R, Icardi G, De Decker M, et al. Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study. Vaccine. 2009;27:7304\u201312.","journal-title":"Vaccine."},{"key":"303_CR20","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1086\/652144","volume":"50","author":"RC Chi","year":"2010","unstructured":"Chi RC, Rock MT, Neuzil KM. Immunogenicity and safety of intradermal influenza vaccination in healthy older adults. CID. 2010;50:1331\u20138.","journal-title":"CID."},{"key":"303_CR21","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1016\/j.vaccine.2010.04.006","volume":"28","author":"B Chuaychoo","year":"2010","unstructured":"Chuaychoo B, Wongsurakiat P, Nana A, et al. The immunogenicity of intradermal influenza vaccination in COPD patients. Vaccine. 2010;28:4045\u201351.","journal-title":"Vaccine."},{"key":"303_CR22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2334-10-134","volume":"10","author":"P Damme Van","year":"2010","unstructured":"Van Damme P, Arnou R, Kafeja F, et al. Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomized comparative study. BMC Infect Dis. 2010;10:134.","journal-title":"BMC Infect Dis"},{"key":"303_CR23","doi-asserted-by":"crossref","first-page":"591","DOI":"10.4161\/hv.23240","volume":"9","author":"F Ansaldi","year":"2013","unstructured":"Ansaldi F, Orsi A, de Florentiis D, et al. Head-to-head comparison of an intradermal and a virosome influenza vaccine in patients over the age of 60: evaluation of immunogenicity, cross-protection, safety and tolerability. Hum Vaccin Immunother. 2013;9:591\u20138.","journal-title":"Hum Vaccin Immunother."},{"key":"303_CR24","doi-asserted-by":"crossref","unstructured":"Hoon Han S, Hee Woo J, Weber F, et al. Immunogenicity and safety of Intanza\u00ae\/IDflu\u00ae intradermal influenza vaccine in South Korean adults: a multicenter, randomized trial. Hum Vaccin Immunother. 2013;9:1971\u20137.","DOI":"10.4161\/hv.25295"},{"key":"303_CR25","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.4161\/hv.25580","volume":"9","author":"DW Scheifele","year":"2013","unstructured":"Scheifele DW, McNeil SA, Ward BJ, et al. Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: results of a randomized, controlled comparison. Hum Vaccin Immunother. 2013;9:2460\u201373.","journal-title":"Hum Vaccin Immunother."},{"key":"303_CR26","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.vaccine.2013.09.074","volume":"32","author":"P Tsang","year":"2014","unstructured":"Tsang P, Gorse GJ, Strout CB, et al. Immunogenicity and safety of Fluzone\u00ae intradermal and high-dose influenza vaccines in older adults\u00a0\u226565\u00a0years of age: a randomized, controlled, phase II trial. Vaccine. 2014;32:2507\u201317.","journal-title":"Vaccine."},{"key":"303_CR27","doi-asserted-by":"crossref","unstructured":"Della Cioppa G, Nicolay U, Lindert K, et al. A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59\u00ae-adjuvanted and non-adjuvanted seasonal influenza vaccines following intradermal and intramuscular administration. Hum Vaccin Immunother. 2014;10:1701\u201310.","DOI":"10.4161\/hv.28618"},{"key":"303_CR28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1742-4933-11-10","volume":"11","author":"B Camilloni","year":"2014","unstructured":"Camilloni B, Basileo M, Di Martino A, et al. Antibody responses to intradermal or intramuscular MF59-adjuvanted influenza vaccines as evaluated in elderly institutionalized volunteers during a season of partial mismatching between vaccine and circulating A(H3N2) strains. Immun Ageing. 2014;11:10.","journal-title":"Immun Ageing."},{"key":"303_CR29","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1128\/CVI.00615-13","volume":"21","author":"YB Seo","year":"2014","unstructured":"Seo YB, Choi WS, Lee J, et al. Comparison of the immunogenicity and safety of the conventional subunit, MF59-adjuvanted, and intradermal influenza vaccines in the elderly. Clin Vaccine Immunol. 2014;21:989\u201396.","journal-title":"Clin Vaccine Immunol"},{"key":"303_CR30","doi-asserted-by":"crossref","unstructured":"Chan TC, Hung IF, Chan KH, et al. Immunogenicity and safety of intradermal trivalent influenza vaccination in nursing home older adults: a randomized controlled trial. J Am Med Dir Assoc. 2014;15:607.e5\u201312.","DOI":"10.1016\/j.jamda.2014.05.002"},{"key":"303_CR31","doi-asserted-by":"crossref","first-page":"6614","DOI":"10.1016\/j.vaccine.2008.09.078","volume":"26","author":"I Leroux-Roels","year":"2008","unstructured":"Leroux-Roels I, Vets E, Freese R, et al. Seasonal influenza vaccine delivered by intradermal microinjection: a randomised controlled safety and immunogenicity trial in adults. Vaccine. 2008;26:6614\u20139.","journal-title":"Vaccine."},{"key":"303_CR32","first-page":"7","volume":"2","author":"J Beran","year":"2009","unstructured":"Beran J, Ambrozaitis A, Laiskonis A, et al. Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial. BMC Med. 2009;2:7\u201313.","journal-title":"BMC Med"},{"key":"303_CR33","doi-asserted-by":"crossref","first-page":"346","DOI":"10.4161\/hv.6.4.10961","volume":"6","author":"R Arnou","year":"2010","unstructured":"Arnou R, Eavis P, Pardo JR, et al. Immunogenicity, large scale safety and lot consistency of an intradermal influenza vaccine in adults aged 18\u201360\u00a0years: randomized, controlled, phase III trial. Hum Vaccin. 2010;6:346\u201354.","journal-title":"Hum Vaccin."},{"key":"303_CR34","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/irv.12000","volume":"7","author":"F Marra","year":"2013","unstructured":"Marra F, Young F, Richardson K, et al. A meta-analysis of intradermal versus intramuscular influenza vaccines: immunogenicity and adverse events. Influenza Other Respir Viruses. 2013;7:584\u2013603.","journal-title":"Influenza Other Respir Viruses"},{"key":"303_CR35","doi-asserted-by":"crossref","first-page":"e24384","DOI":"10.1371\/journal.pone.0024384","volume":"6","author":"L Manzoli","year":"2011","unstructured":"Manzoli L, De Vito C, Salanti G, et al. Meta-analysis of the immunogenicity and tolerability of pandemic influenza A 2009 (H1N1) vaccines. PLoS One. 2011;6:e24384.","journal-title":"PLoS One"},{"key":"303_CR36","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/B978-1-4160-3611-1.50065-9","volume-title":"Vaccines","author":"BG Weniger","year":"2008","unstructured":"Weniger BG, Papania MJ. Alternative vaccine delivery methods. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 5th ed. Philadelphia: Elsevier; 2008. p. 1357\u201392.","edition":"5"},{"key":"303_CR37","doi-asserted-by":"crossref","first-page":"336","DOI":"10.4161\/hv.6.4.10753","volume":"6","author":"C Reygrobellet","year":"2010","unstructured":"Reygrobellet C, Viala-Danten M, Meunier J, et al. Perception and acceptance of intradermal influenza vaccination: patient reported outcomes from phase 3 clinical trials. Hum Vaccin. 2010;6:336\u201345.","journal-title":"Hum Vaccin."},{"key":"303_CR38","first-page":"134","volume":"113","author":"JE Foy","year":"2013","unstructured":"Foy JE, Hendriksz T, Malouf P, et al. Acceptability of fluzone intradermal vaccine to patients and vaccine administrators. J Am Osteopath Assoc. 2013;113:134\u201343.","journal-title":"J Am Osteopath Assoc"},{"key":"303_CR39","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s12325-012-0012-1","volume":"29","author":"P Durando","year":"2012","unstructured":"Durando P, Alicino C, Alberti M, et al. Acceptance and safety of the intradermal influenza vaccine among the elderly in Italy: an on-field national study. Adv Ther. 2012;29:312\u201326.","journal-title":"Adv Ther."},{"key":"303_CR40","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1016\/j.vaccine.2012.05.011","volume":"30","author":"A Taddio","year":"2012","unstructured":"Taddio A, Ipp M, Thivakaran S, et al. Survey of the prevalence of immunization on non-compliance due to needle fears in children and adults. Vaccine. 2012;30:4807\u201312.","journal-title":"Vaccine."},{"key":"303_CR41","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/eurpub\/14.3.258","volume":"14","author":"C Pileggi","year":"2004","unstructured":"Pileggi C, Carbone V, Pavia M, et al. Patients\u2019 perceptions and related behaviours on role of primary care physician in Italy. Eur J Public Health. 2004;14:258\u201360.","journal-title":"Eur J Public Health."},{"key":"303_CR42","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0033-3506(03)00066-0","volume":"117","author":"M Pavia","year":"2003","unstructured":"Pavia M, Foresta MR, Carbone V, et al. Influenza and pneumococcal immunization in the elderly: knowledge, attitudes, and practices among general practitioners in Italy. Public Health. 2003;117:202\u20137.","journal-title":"Public Health."},{"key":"303_CR43","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1016\/j.vaccine.2012.02.003","volume":"30","author":"F Ansaldi","year":"2012","unstructured":"Ansaldi F, Canepa P, Ceravolo A, et al. Intanza\u00ae 15 mcg intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses. Vaccine. 2012;30:2908\u201313.","journal-title":"Vaccine."},{"key":"303_CR44","doi-asserted-by":"crossref","first-page":"582","DOI":"10.4161\/hv.23239","volume":"9","author":"A Orsi","year":"2013","unstructured":"Orsi A, Ansaldi F, de Florentiis D, et al. Cross-protection against drifted influenza viruses: options offered by adjuvanted and intradermal vaccines. Hum Vaccin Immunother. 2013;9:582\u201390.","journal-title":"Hum Vaccin Immunother."},{"key":"303_CR45","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.coi.2005.07.020","volume":"17","author":"JJ Goronzy","year":"2005","unstructured":"Goronzy JJ, Weyand CM. T cell development and receptor diversity during aging. Curr Opin Immunol. 2005;17:468\u201375.","journal-title":"Curr Opin Immunol"},{"key":"303_CR46","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.arr.2010.10.008","volume":"10","author":"JE McElhaney","year":"2011","unstructured":"McElhaney JE. Influenza vaccine responses in older adults. Ageing Res Rev. 2011;10:379\u201388.","journal-title":"Ageing Res Rev."}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-015-0303-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40266-015-0303-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-015-0303-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T07:30:13Z","timestamp":1599636613000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40266-015-0303-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["303"],"URL":"https:\/\/doi.org\/10.1007\/s40266-015-0303-8","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}